Laparoscopic cytoreductive nephrectomy: The M. D. Anderson Cancer Center experience

Urology

Volumn 68, Issue 3, 2006, Pages 528-532

  Matin, Surena F ^a   Madsen, Lydia T ^a   Wood, Christopher G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CANCER CENTER; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEPHRECTOMY; OPERATION DURATION; PERFORMANCE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SYSTEMIC THERAPY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; MIDDLE AGED; NEPHRECTOMY;

EID: 33748935733     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.03.076     Document Type: Article

References (15)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Flanigan R.C., and Yonover P.M. The role of radical nephrectomy in metastatic renal cell carcinoma. Semin Urol Oncol 19 (2001) 98-102
3. Bennett R.T., Lerner S.E., Taub H.C., et al. Cytoreductive surgery for stage IV renal cell carcinoma. J Urol 154 (1995) 32-34
4. Mickisch G.H., Garin A., van Poppel H., and members of the European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358 (2001) 966-970
5. Wood C.G. The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma. Urol Clin North Am 30 (2003) 581-588
6. Varkarakis I.M., Bhayani S.B., Allaf M.E., et al. Laparoscopic-assisted nephrectomy with inferior vena cava tumor thrombectomy: preliminary results. Urology 64 (2004) 925-929
7. Saika T., Ono Y., Hattori R., et al. Long-term outcome of laparoscopic radical nephrectomy for pathologic T1 renal cell carcinoma. Urology 62 (2003) 1018-1023
8. Walther M.M., Lyne J.C., Libutti S.K., et al. Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study. Urology 53 (1999) 496-501
9. Rabets J.C., Kaouk J., Fergany A., et al. Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinoma. Urology 64 (2004) 930-934
10. Nakada S.Y. Hand-assisted laparoscopic nephrectomy. J Endourol 13 (1999) 9-15
11. Gill I.S., Meraney A.M., Schweizer D.K., et al. Laparoscopic radical nephrectomy in 100 patients: a single center experience from the United States. Cancer 92 (2001) 1843-1855
12. Flanigan R.C., Mickisch G., Sylvester R., et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 171 (2004) 1071-1076
13. Motzer R.J., Bacik J., Schwartz L.H., et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 22 (2004) 454-463
14. Pautler S.E., Richards C., Libutti S.K., et al. Intentional resection of the diaphragm during cytoreductive laparoscopic radical nephrectomy. J Urol 167 (2002) 48-50
15. Levy D.A., Swanson D.A., Slaton J.W., et al. Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma. J Urol 159 (1998) 1168-1173